CorMatrix Cardiovascular said today it enrolled the 1st patient in a trial of its CorMatrix ECM tricuspid valve designed from regenerative tissue. The early feasibility trial aims to demonstrate proof of principle and initial clinical safety at 8 U.S. centers, the Roswell, Ga.-based company said. CorMatrix is performing the trial under an investigative device exemption […]
Regenerative Medicine
Orthofix puts $1.3m into Musculoskeletal Transplant Foundation deal
Orthofix (NSDQ:OFIX) said last week it is investing $1.3 million into the Musculoskeletal Transplant Foundation through a collaborative agreement to support the procurement and installation of equipment and tech at MTF’s Edison, N.J. facilities. Lewisville, Texas-based Orthofix has maintained a collaborative agreement with MTF since 2008 to support the commercialization of its Trinity Evolution and Trinity […]
Mass General researchers regenerate working heart muscle in decellularized human hearts
Researchers at Massachusetts General Hospital have regenerated functional heart muscle in a decellularized human heart. The donated hearts used in the study were stripped of components that would generate an immune response, and the regenerated tissue was generated from induced pluripotent stem cells, which the researchers said could come from a potential recipient. Investigators said […]
Avita Medical inks China distro deal with Sinopharm
Avita Medical (ASX:AVH) said today it inked an exclusive Chinese distribution deal with Chinese healthcare group Sinopharm. The deal will grant Sinopharm’s MedTech subsidiary exclusive distribution rights for the range of Avita’s medical devices, including regenerative treatments for burns, chronic wounds and skin defects, Avita said. Shares in Avita rose approximately 2% in early day […]
Regenerative firm Creative Medical launches cardio-focused AngioStem biz
Regenerative biotech company Creative Medical Health said today it is launching a subsidiary biz, AngioStem, to commercialize its cardiovascular assets. Assets on hand for the newly launched company include a therapy that uses autologous and allogeneic adult stem cells in combination with modulation of oxidative stress to treat heart failure in patients with cardiovascular disease, […]
CollPlant jumps on CE Mark win for wound filler
CollPlant said today it won CE Mark approval in the European Union for its Vergenix FG flowable gel intended to treat chronic and acute wounds. In response to the news, the company’s share price was up 4.62% on the Tel Aviv Stock Exchange at midday. The wound-filling gel utilizes Israel-based CollPlant’s proprietary tobacco plant-based technology […]
InVivo Therapeutics enrolls 6th patient in spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) shares are up this morning on the spinal scaffold maker’s announcement that it enrolled the 6th patient in its Inspire pivotal clinical trial. The patient, who’s being treated at the Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, Mo., was implanted with the InVivo device about 10 hours after a traumatic spinal injury, the […]
Avita inks deal with EU distro deal with MSM Medical
Avita Medical (ASX:AVH) said today it inked a distribution deal with MSM Medical that will put the company in charge of selling its devices into the German, Austrian and Swiss markets. German-based MSM Medical sells advanced woudn care products in key german speaking territories, and has 8 offices in the country. The agreement came into effect […]
Biomaterial startup Regentis raises $15m
Israeli start-up Regentis Biomaterials said yesterday it raised $15 million in a Series D round of funding to support its GelrinC hydrogel-based resorbable cartilage replacement. Funds from the round will be used to support a pivotal clinical trial for GelrinC in the U.S., and to obtain marketing approval from the FDA. Regentis’ GelrinC is implanted […]
CorMatrix wins FDA nod for Tyke neonate cardiac tissue
CorMatrix Cardiovascular said today it won FDA 510(k) clearance for its Tyke biomaterial for use in neonates and infants. The patch is designed to repair pericardial structures and as an epicardial covering or for intracardiac defects, septal defects, annulus repair, suture-line buttressing. The Tyke is derived from the company’s ECM technology platform and is composed […]
Bio-Rad picks up cytometer platform from Propel
Bio-Rad Laboratories (NYSE:BIO) said today it acquired Propel Labs high performance analytical flow cytometer platform, with a planned instrument launch from the acquisition later this year. Flow cytometry is a technique used to identify and sort cells and their components, Hercules, Calif.-based Bio-Rad Laboratories said. “We welcome the opportunity to expand our relationship with Propel […]